N/A
N=161
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Type 1 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02074384 ↗Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Jan 2016
Primary outcome: Primary: Portion of Study Participants Reporting Greater Utility From AGP vs. Traditional Glucose Data Reports — 35; 29; 10 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Continuous Glucose Monitor (Device); Self Monitoring Blood Glucose (Device); Clinician (Other)
- Age
- Pediatric, Adult, Older Adult · 7+ yrs
- Sex
- All
- Sponsor
- HealthPartners Institute
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Portion of Study Participants Reporting Greater Utility From AGP vs. Traditional Glucose Data Reports |
35; 29; 10 | — |
Summary
International Diabetes Center (IDC) proposes a preference and usability study of glucose data acquisition and reporting, evaluating streamlined standardized cloud-based glucose reporting including work flow as well as patient and clinician preference at Type 1 Diabetes (T1D) Exchange sites to enhance standard Ambulatory Glucose Profile (AGP) reporting. This phase 2 project assesses the efficacy of standardized glucose data report generation and preferred report presentation format; both are necessary to increase use of continuous glucose monitoring (CGM) data to improve care processes and outcomes for Type 1 diabetes.
Eligibility Criteria
Inclusion Criteria
- Type 1 Diabetics
Exclusion Criteria
- Less than the age of 7
- Non-English Speaker
Data sourced from ClinicalTrials.gov (NCT02074384). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.